We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

7th December 2009
Selected Chemistry & Industry magazine issue

Select an Issue


C&I e-books

C&I e-books

C&I apps

iOS App
Android App

Computing clean energy Computing clean energy

High performance computing is supercharging research into clean energy solutions.

Read the feature article


Consolidation is on the cards for chemicals

Patrick Walter, December 2009

As the market begins to pick up again, businesses are looking for good deals in the chemical industry.


Biowarfare on the farm

Neil Eisberg, December 2009

Even producers of synthetic agrochemicals are moving into biological pesticides, using plant oils and other naturally occurring chemicals. Neil Eisberg reports on developments discussed at the fall meeting of the American Chemical Society in Washington, DC


Product Focus

Metrohm Product Focus


There are no postcards for the issue of C&I Magazine which you have selected.

Click here to see other postcards from our international correspondents.

International Youth DayAugust 15, 2016


Treating with science

Steve Fuller, December 2009

The Lisbon Treaty offers the EU an opportunity to make science policy more than just a handmaiden of economic policy, argues Steve Fuller


Collision course

Michael Gross, December 2009

On 10 September 2008, the first proton beams entered the circular racecourse known as the Large Hadron Collider (LHC), buried deep in the ground under the French-Swiss border near Geneva, Switzerland.


Analytical chemistry

Tom McCreedy, December 2009

On-line monitoring of haloacetic acid species

The chlorination of drinking water has reduced outbreaks of waterborne diseases but has lead to the formation of some undesirable byproducts of the disinfection process, for example, trihalomethanes.


Movers & shakers

December 2009

Pharmaceutical major Eli Lilly has appointed Jan Lundberg executive vp, science and technology, and president, Lilly Research Laboratories, effective January 2010. Lundberg is executive vp and head of global discovery research at AstraZeneca.

Nura - Evaluating toxicological information using modern science